MYGN announcements Myriad Genetics, Inc. announcements and dividends declared NASDAQ
Myriad Genetics, Inc. Complete list of announcements declared & dividend announcements by Myriad Genetics, Inc. MYGN
Myriad Genetics, Inc. MYGN listed on NASDAQ and deals in Health Care Biotechnology In Vitro In Vivo Diagnostic SubstancesAnnouncements and dividends declared by Myriad Genetics, Inc. MYGN
Wells Fargo Initiates Coverage of Myriad Genetics (MYGN) with Overweight Recommendation
Fintel reports that on August 27, 2024, Wells Fargo initiated coverage of Myriad Genetics (NasdaqGS:MYGN) with a Overweight recommendation.
Announcement as on 29 August 2024
Myriad Genetics (MYGN) Tops Q4 Earnings and Revenue Estimates
Myriad Genetics (MYGN) came out with quarterly earnings of [CO].04 per share, beating the Zacks Consensus Estimate of [CO].02 per share. This compares to loss of [CO].12 per share a year ago. These figures are adjusted for non-recurring
Announcement as on 27 February 2024
Reasons to Hold on to Myriad Genetics (MYGN) Stock for Now
Myriad Genetics, Inc. MYGN has been gaining from robust first-quarter 2022 results. Spectacular improvement in Pharmacogenomics testing revenues, along with growth in tumor profiling and GeneSight test volumes, looks encouraging. However, stiff competition
Announcement as on 26 May 2022
Here's Why You Should Retain Myriad Genetics (MYGN) for Now
Myriad Genetics, Inc. MYGN is well poised for growth in the coming quarters on the ongoing strong recovery in testing volumes. The company’s recent launches of myRisk and RiskScore raise optimism. A strong solvency position is an added advantage. However
Announcement as on 04 October 2021
Here's Why You Should Retain Myriad Genetics (MYGN) for Now
Myriad Genetics, Inc. MYGN is well poised for growth in the coming quarters on the ongoing strong recovery in testing volumes. The company’s recent launches of myRisk and RiskScore raise optimism. A strong solvency position is an added advantage. However
Announcement as on 04 October 2021
Announcements by Myriad Genetics, Inc. first page | Next page |
MYGN Myriad Genetics, Inc. current price & indicator signals
Recent prices of MYGN Myriad Genetics, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 28 Fri Mar 2025 | 8.88 | 8.70 to 9.43 | -3.58% | 0.65 times |
| 26 Wed Mar 2025 | 9.21 | 9.19 to 9.88 | -7.72% | 0.66 times |
| 24 Mon Mar 2025 | 9.98 | 9.90 to 10.26 | -0.3% | 0.71 times |
| 21 Fri Mar 2025 | 10.01 | 9.68 to 10.30 | 1.01% | 2.05 times |
| 20 Thu Mar 2025 | 9.91 | 9.73 to 9.98 | -0.2% | 0.61 times |
| 19 Wed Mar 2025 | 9.93 | 9.77 to 10.06 | 0.3% | 0.74 times |
| 18 Tue Mar 2025 | 9.90 | 9.72 to 10.00 | -2.17% | 0.83 times |
| 17 Mon Mar 2025 | 10.12 | 9.87 to 10.32 | 0.5% | 0.81 times |
| 14 Fri Mar 2025 | 10.07 | 9.75 to 10.19 | 3.81% | 0.77 times |
| 13 Thu Mar 2025 | 9.70 | 9.69 to 10.47 | -6.82% | 0.95 times |
| 12 Wed Mar 2025 | 10.41 | 10.36 to 11.44 | 1.56% | 1.87 times |
| 11 Tue Mar 2025 | 10.25 | 9.50 to 10.30 | 6.77% | 1.5 times |
Videos related to: MYGN announcements Myriad Genetics, Inc. announcements and dividends declared NASDAQ
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance